You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 1, January 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

Charlotte Marker Zitrin, MD; Donald F. Klein, MD; Margaret G. Woerner, PhD

Arch Gen Psychiatry. 1980;37(1):63-72.


Abstract

• Seventy-six white agoraphobic women, 21 to 45 years old, were treated with combined group exposure in vivo and imipramine or placebo in a randomized double-blind study. A majority of the patients in both the placebo and imipramine groups showed moderate to marked improvement. However, imipramine therapy was significantly superior to placebo therapy on three of the four reported measures of improvement: primary phobia, spontaneous panic, and global improvement. There was a negative correlation between depression and outcome; ie, the more depressed patients fared worse on several outcome measures than those who were less depressed. A comparison of these patients with agoraphobic women previously treated with imipramine and imaginal desensitization showed a superiority of exposure in vivo midway in treatment, but no significant difference between the two groups at the completion of therapy.



Author Affiliations

From the Department of Psychiatry, Long Island Jewish-Hillside Medical Center, Glen Oaks, NY. Dr Klein is now with the New York State Psychiatric Institute and Columbia University College of Physicians and Surgeons, New York, NY.


Footnotes

Accepted for publication July 9, 1979.

Reprint requests to Department of Psychiatry, Long Island Jewish-Hillside Medical Center, Box 38, Glen Oaks, NY 11004 (Dr Zitrin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psychotherapy Plus Antidepressant for Panic Disorder With or Without Agoraphobia: Systematic Review
Furukawa et al.
Focus 2008;6:528-538.
ABSTRACT | FULL TEXT  

Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic review
FURUKAWA et al.
Br. J. Psychiatry 2006;188:305-312.
ABSTRACT | FULL TEXT  

A dose-finding and discontinuation study of clomipramine in panic disorder
Lotufo-Neto et al.
J Psychopharmacol 2001;15:13-17.
ABSTRACT  

Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder: A Randomized Controlled Trial
Barlow et al.
JAMA 2000;283:2529-2536.
ABSTRACT | FULL TEXT  

Panic Control Treatment and Its Applications
Hofmann and Spiegel
J. Psychother. Pract. Res. 1999;8:3-11.
ABSTRACT | FULL TEXT  

Stopping panic attacks
DTB 1997;35:58-62.
ABSTRACT | FULL TEXT  

Outcomes of Group Cognitive Behavioral Training in the Treatment of Panic Disorder And Agoraphobia
Schweitzer et al.
J Am Psychiatr Nurses Assoc 1995;1:83-90.
ABSTRACT  

Clomipramine, a better reference drug for panic/agoraphobia. II. Psychomotor and cognitive effects
Marcourakis et al.
J Psychopharmacol 1993;7:325-330.
ABSTRACT  

Maintenance Drug Treatment of Panic Disorder: I. Results of a Prospective, Placebo-Controlled Comparison of Alprazolam and Imipramine
Schweizer et al.
Arch Gen Psychiatry 1993;50:51-60.
ABSTRACT  

Maintenance Drug Treatment for Panic Disorder: II. Short- and Long-term Outcome After Drug Taper
Rickels et al.
Arch Gen Psychiatry 1993;50:61-68.
ABSTRACT  

Follow-up Study of Patients With Panic Disorder
Judd et al.
Arch Gen Psychiatry 1991;48:860-861.
ABSTRACT  

Imipramine in panic disorder. 1. Clinical response and pharmacological changes
Nutt and Glue
J Psychopharmacol 1991;5:56-64.
ABSTRACT  

Psychology and pharmacology in the treatment of anxiety disorders: co-operation or confrontation
Middleton
J Psychopharmacol 1991;5:281-285.
ABSTRACT  

'Psychological inflammation'. Clarification of the model and a rejoinder
Middleton
J Psychopharmacol 1991;5:301-304.
 

Outcome of Panic Disorder: Relationship to Diagnostic Subtypes and Comorbidity
Noyes et al.
Arch Gen Psychiatry 1990;47:809-818.
ABSTRACT  

Clinical and Medication Outcome After Short-term Alprazolam and Behavorial Group Treatment in Panic Disorder: 2.5-Year Naturalistic Follow-up Study
Nagy et al.
Arch Gen Psychiatry 1989;46:993-999.
ABSTRACT  

Panic Attacks Facilitating Recall and Mastery: Implications for Psychoanalytic Technique
Silber
J Am Psychoanal Assoc 1989;37:337-364.
ABSTRACT  

Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial: I. Efficacy in Short-term Treatment
Ballenger et al.
Arch Gen Psychiatry 1988;45:413-422.
ABSTRACT  

Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial: II. Patient Acceptance, Side Effects, and Safety
Noyes et al.
Arch Gen Psychiatry 1988;45:423-428.
ABSTRACT  

Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial: III. Discontinuation Effects
Pecknold et al.
Arch Gen Psychiatry 1988;45:429-436.
ABSTRACT  

The Cause and Treatment of Agoraphobia-Reply
Klein
Arch Gen Psychiatry 1988;45:389-392.
ABSTRACT  

Panic and Avoidance in Agoraphobia: Application of Path Analysis to Treatment Studies
Klein et al.
Arch Gen Psychiatry 1987;44:377-385.
ABSTRACT  

Imipramine and Chlordiazepoxide in Depressive and Anxiety Disorders: I. Efficacy in Depressed Outpatients
Lipman et al.
Arch Gen Psychiatry 1986;43:68-77.
ABSTRACT  

Noradrenergic Function and the Mechanism of Action of Antianxiety Treatment: II. The Effect of Long-term Imipramine Treatment
Charney and Heninger
Arch Gen Psychiatry 1985;42:473-481.
ABSTRACT  

Lactate Provocation of Panic Attacks: I. Clinical and Behavioral Findings
Liebowitz et al.
Arch Gen Psychiatry 1984;41:764-770.
ABSTRACT  

Panic-Induced Elevation of Plasma MHPG Levels in Phobic-Anxious Patients: Effects of Clonidine and Imipramine
Ko et al.
Arch Gen Psychiatry 1983;40:425-430.
ABSTRACT  

Treatment of Phobias: I. Comparison of Imipramine Hydrochloride and Placebo
Zitrin et al.
Arch Gen Psychiatry 1983;40:125-138.
ABSTRACT  

Treatment of Phobias: II. Behavior Therapy and Supportive Psychotherapy: Are There Any Specific Ingredients?
Klein et al.
Arch Gen Psychiatry 1983;40:139-145.
ABSTRACT  

Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure Homework
Marks et al.
Arch Gen Psychiatry 1983;40:153-162.
ABSTRACT  

Treatment of Agoraphobia and Panic Attacks
Matuzas and Glass
Arch Gen Psychiatry 1983;40:220-222.
ABSTRACT  

Response to Phenelzine and Amitriptyline in Subtypes of Outpatient Depression
Paykel et al.
Arch Gen Psychiatry 1982;39:1041-1049.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.